BioTuesdays

Category - Executive Moves

Titan Pharmaceuticals

Titan Pharma adds two members to BOD

Titan Pharmaceuticals (NASDAQ:TTNP), in a move to boost its product development and commercialization experience in the U.S., Europe and Asia, named Scott Smith and Dr. Rajinder Kumar to its board.

Microbix names Jim Currie as CFO

Microbix Biosystems (TSX:MBX) appointed Jim Currie as CFO, succeeding Charles Wallace, who is retiring at the end of the year.Mr. Currie was most recently CFO of SMTC, a global electronics manufacturing services company...

Jason Flowerday named CEO of 3D Signatures

3D Signatures (TSX-V:DXD) has appointed Jason Flowerday as CEO. He succeeds Ferenc Somogyvari, who will remain on the board."Mr. Flowerday is a highly respected biotech entrepreneur with more than 20 years of executive...

Subscribe

Sign up to our weekly BioTuesdays newsletter.